1
项与 MB-11 (mAbxience) 相关的临床试验Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)
This is a randomised, multicentre, multinational, double-blind, integrated study to sompare the pharmacokinetics, efficacy, safety, and immunogenicity of MB11 versus Opdivo® in subjects with previously untreated advanced (unresectable or Metastatic) Melanoma
100 项与 MB-11 (mAbxience) 相关的临床结果
100 项与 MB-11 (mAbxience) 相关的转化医学
100 项与 MB-11 (mAbxience) 相关的专利(医药)
100 项与 MB-11 (mAbxience) 相关的药物交易